|
C5ORF33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95166105498856E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69969593954988E-11 |
| Normal-vs-Stage2 |
1.95339966424513E-10 |
| Normal-vs-Stage3 |
1.55339999974302E-07 |
| Normal-vs-Stage4 |
1.2864999999751E-06 |
| Stage1-vs-Stage2 |
2.799000E-01 |
| Stage1-vs-Stage3 |
8.544800E-01 |
| Stage1-vs-Stage4 |
4.342000E-01 |
| Stage2-vs-Stage3 |
6.147000E-01 |
| Stage2-vs-Stage4 |
6.189400E-01 |
| Stage3-vs-Stage4 |
5.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6286971771251E-12 |
| Normal-vs-AfricanAmerican |
9.43900002603471E-09 |
| Normal-vs-Asian |
1.081920E-02 |
| Caucasian-vs-AfricanAmerican |
1.761180E-01 |
| Caucasian-vs-Asian |
4.459000E-01 |
| AfricanAmerican-vs-Asian |
7.943200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.66400000001232E-06 |
| Male-vs-Female |
3.086200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.01380048589795E-10 |
| Normal-vs-Extreme_Weight |
1.65323310596932E-12 |
| Normal-vs-Obese |
1.3555999989201E-08 |
| Normal-vs-Extreme_Obese |
1.155290E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.735400E-01 |
| Normal_Weight-vs-Obese |
1.836020E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.691200E-01 |
| Extreme_Weight-vs-Obese |
9.699500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.077200E-01 |
| Obese-vs-Extreme_Obese |
8.269400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32170000000043E-05 |
| Normal-vs-Age(41-60Yrs) |
1.45400025353126E-10 |
| Normal-vs-Age(61-80Yrs) |
3.66373598126302E-15 |
| Normal-vs-Age(81-100Yrs) |
1.52654999999724E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.418000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.995230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.073800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.282600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.949000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62703184258817E-12 |
| Normal-VS-Type2 PRCC |
3.31570326750352E-11 |
| Normal-VS-KIRP CIMP |
3.63790000001973E-06 |
| Normal-VS-Unclassified PRCC |
5.52360000000141E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.350200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.188200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.861600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.084200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.754590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.702600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.74059680399819E-11 |
| Normal-vs-N1 |
1.92180000024855E-07 |
| Normal-vs-N2 |
7.357700E-04 |
| N0-vs-N1 |
5.616800E-01 |
| N0-vs-N2 |
3.624800E-01 |
| N1-vs-N2 |
1.973980E-01 |
|
|
